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Objective: To determine the influence of the total cumulative exposure to excess overall and abdominal
adiposity on the incidence of cardiovascular disease (CVD).
Methods: Prospective study of 4,061 white and black adults without CVD at baseline in 1985-1986 (age
18-30 years) from the multicenter, community-based CARDIA study. Time-varying excess body mass
index (BMI)- and waist circumference (WC)-years were calculated as products of the degree and duration
of excess overall (BMI25 kg/m2) and abdominal adiposity [WC >94 cm (men) and >80 cm (women)],
respectively, collected at up to eight examinations.
Results: During a median of 24.8 years, there were 125 incident CVD, 62 coronary heart disease (CHD),
and 33 heart failure (HF) events. Adjusted hazard ratios for CVD, CHD, and HF for each additional 50
excess BMI-years were 1.20 (1.08, 1.34), 1.25 (1.07, 1.46), and 1.45 (1.23, 1.72), respectively. For each
50 excess WC-years, these hazard ratios were 1.10 (1.04, 1.18), 1.13 (1.03, 1.24), and 1.22 (1.11, 1.34),
respectively. Akaike information criterion values were lowest in models containing time-varying excess
BMI- or WC-years compared to those including time-varying BMI or WC only.
Conclusions: Excess BMI- and WC-years are predictors of the risk of CVD and may provide a better
indicator of the cumulative exposure to excess adiposity than BMI or WC only.
Obesity (2015) 23, 879-885. doi:10.1002/oby.21023
Introduction
Over the last 30 years, the prevalence of obesity has increased mark-
edly in the United States, with a doubling of rates among adults,
and a tripling of rates among children and adolescents (1,2). The
acceleration of obesity trends among younger populations is particu-
larly concerning given the persistence of obesity into adulthood (3).
With obesity occurring at younger ages, the children and young
adults of today will carry and express obesity-related risks for more
of their lifetime than any other previous generation. This may have
significant implications for an unprecedented acceleration of
obesity-related morbidity and mortality. Yet few long-term studies
have evaluated the consequences of a greater cumulative exposure
to a higher degree of adiposity and longer duration of obesity in
young adults during the obesity epidemic. Most available studies
have focused on the degree of adiposity [either overall or abdominal
adiposity reflected by body mass index (BMI) or waist circumfer-
ence, respectively] as an important risk factor in the development of
cardiovascular disease (CVD) and related conditions, but not the
impact of the duration of excess adiposity (4). More recently, dura-
tion of obesity has been linked with progression to diabetes and sub-
clinical atherosclerosis, as well as a higher risk of mortality, inde-
pendent of the degree of adiposity (5-8).
In the current study, we sought to determine the influence of meas-
ures of the total cumulative exposure to excess overall and abdominal
adiposity, expressed as excess BMI- and waist circumference-years,
respectively, on the incidence of CVD in the Coronary Artery Risk
Development in Young Adults (CARDIA) study. Excess BMI and
waist circumference-years are products of the degree of adiposity and
duration of overweight/obesity, similar to the concept of pack-years,
a frequently used cumulative measure of the quantity and duration of
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smoking (9). CARDIA provides a unique opportunity to study the
cumulative impact of the obesity epidemic on the risk of incident
CVD because the community-based cohort of young adults was
recruited at the start of the obesity epidemic in the United States and
has been followed continuously ever since with repeat assessments of
anthropometry approximately every 2-5 years. We hypothesized that
a greater cumulative exposure would be associated in a dose-response
fashion with incident CVD. In addition, we hypothesized that excess
BMI- and waist circumference-years would better predict CVD than
only BMI or waist circumference attained over time.
Methods
Study population
CARDIA is a multicenter community-based longitudinal cohort
study of the development and determinants of CVD in 5,115 young
adults initially aged 18-30 years in 1985-1986 (10). To date, partici-
pants have been re-examined 2, 5, 7, 10, 15, 20, and 25 years after
baseline and retention rates for the surviving cohort across examina-
tions were 91%, 86%, 81%, 79%, 74%, 72%, and 72%, respectively.
All participants provided written informed consent at each examina-
tion, and institutional review boards from each field center and the
coordinating center approved the study annually.
Of the 5,115 participants, we excluded those with missing BMI or
waist circumference values at baseline (n5 24), women who were
pregnant at any examination (n5 239), those who reported bariatric
surgery during follow-up (n5 68), and those without BMI or waist
circumference measured after baseline (n5 723). The remaining
4,061 participants formed the sample population for analysis.
Clinical measurements
Standardized protocols for data collection were used across study
centers and examinations. Participants were asked to fast for at least
12 h and to avoid smoking or engaging in heavy physical activity
for at least 2 h before each examination.
Anthropometry
Weight and height were measured with participants wearing light
examination clothes and no shoes. Body weight was measured to the
nearest 0.2 kg with a calibrated balance-beam scale. Height was
measured with a vertical ruler to the nearest 0.5 cm. BMI was calcu-
lated as weight in kilograms divided by height in meters squared.
Waist circumference was measured with a Gulick 2 anthropometric
tape with tensioning mechanism in duplicate to the nearest 0.5 cm
around the minimal abdominal girth identified laterally midway
between the iliac crest and the lowest portion of the rib cage and
anteriorly midway between the xiphoid process and the umbilicus.
Additional circumference measures (e.g., hip circumference) at all
examinations were unavailable.
Excess BMI- and waist circumference-years
To account for BMI and waist circumference during follow-up years
between examinations, we averaged values between adjacent exami-
nations and assigned this value to each interim follow-up year. If
BMI or waist circumference at an examination was missing, we used
the value at the next available examination. For example, a partici-
pant with BMI values of 28, 30, and 32 kg/m2 at baseline, year 2, and
year 5, respectively, was assigned a BMI of 29 kg/m2 at year 1 and
31 kg/m2 at years 3 and 4. If the examined or interpolated BMI value
for each follow-up year was 25 kg/m2 (or for waist circumference
>94 cm for men or >80 cm for women) (11,12), we subtracted a ref-
erence BMI of 24 kg/m2 (for waist circumference 94 cm for men and
80 cm for women) from each value to calculate excess BMI (or waist
circumference) at each year. If the examined or interpolated BMI was
<25 kg/m2 (or for waist circumference 94 cm for men and 80 cm
for women), excess BMI (or waist circumference) was set to 0. For
example, a participant with an examined BMI of 24 kg/m2 at base-
line, 25 at year 1, and 26 at year 2, would have excess BMI values of
0, 1, and 2 kg/m2 for those years, respectively. We then accounted
for duration of overweight/obesity by summing excess BMI and waist
circumference over all years up to the development of a CVD event
to calculate excess BMI- and waist circumference-years, respectively.
For those who did not develop CVD, excess BMI and waist circum-
ference were summed until the date of death or date of last contact.
Ascertainment of CVD
We recorded new CVD events through September 2011. During
their scheduled study examinations and yearly telephone interviews,
each participant or designated proxy was asked about interim hospi-
tal admissions, outpatient procedures, and deaths. Medical records
were requested for participants who had been hospitalized or
received an outpatient revascularization procedure. Vital status was
assessed every 6 months; medical and other death records were
requested after consent had been obtained from the next of kin.
Two physician members of the CARDIA endpoints surveillance and
adjudication committee independently classified events and assigned
incident dates. If they disagreed, the full committee made the final
decision. For the purposes of this study, total CVD events comprised
the incidence of coronary heart disease (CHD) (myocardial infarction,
hospitalization for angina/acute coronary syndrome, or CHD death,
including fatal myocardial infarction), heart failure (HF), stroke (fatal
or non-fatal), transient ischemic attack, or peripheral arterial disease.
Other measurements
Detailed information on the collection of other measurements is
available in the Supporting Information.
Statistical analysis
Participant characteristics overall, and according to excess BMI- and
waist circumference-years were described using means, medians, or
proportions as appropriate. Differences and trends were tested using
linear regression models and v2 analyses for continuous and categor-
ical characteristics, respectively. The Kruskal-Wallis test was used
for characteristics with skewed distributions. We calculated the inci-
dence rate of CVD, CHD, or HF (number of incident cases per per-
son time at risk) per 1,000 person-years overall and according to
excess BMI- and waist circumference-years accumulated. Follow-up
time at risk was calculated as the difference between baseline and
the incident date of CVD, CHD, or HF. For participants who did
not experience a CVD, CHD, or HF event, follow-up time was cen-
sored at the date of death or the date of last contact.
Multivariable Cox proportional hazards regression models were used
to estimate hazard ratios (HR) and 95% confidence intervals (CI)
Obesity Excess Adiposity and Cardiovascular Disease Reis et al.
880 Obesity | VOLUME 23 | NUMBER 4 | APRIL 2015 www.obesityjournal.org
TA
B
LE
1
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
a
c
c
o
rd
in
g
to
c
a
te
g
o
ri
e
s
o
f
e
x
c
e
s
s
b
o
d
y
m
a
s
s
in
d
e
x
(B
M
I)
-y
e
a
rs
,
T
h
e
C
A
R
D
IA
s
tu
d
y
(n
5
4
,0
6
1
)
E
x
c
e
s
s
B
M
I-
y
e
a
rs
V
a
ri
a
b
le
a
0
(n
5
1
,1
0
3
)
1
-4
9
(n
5
9
8
6
)
5
0
-9
9
(n
5
7
2
1
)
1
0
0
-1
4
9
(n
5
4
9
4
)
1
5
0
(n
5
7
5
7
)
P
-t
re
n
d
Se
le
ct
ed
ch
ar
ac
te
ris
tic
s
Ba
se
lin
e
ag
e
(y
ea
rs
)
24
.7
(3
.6
)
24
.9
(3
.7
)
24
.9
(3
.5
)
25
.1
(3
.5
)
24
.7
(3
.8
)
0.
6
W
om
en
,
%
(n
)
57
.1
(6
30
)
45
.5
(4
49
)
44
.5
(3
21
)
40
.3
(1
99
)
55
.2
(4
18
)
0.
06
Bl
ac
k
ra
ce
,
%
(n
)
39
.0
(4
30
)
44
.8
(4
42
)
49
.1
(3
54
)
54
.3
(2
68
)
62
.5
(4
73
)
<
0.
00
1
Ed
uc
at
io
na
l
at
ta
in
m
en
t
(y
ea
rs
)
15
.3
(2
.8
)
15
.5
(2
.7
)
15
.3
(2
.5
)
15
.3
(2
.6
)
15
.0
(2
.5
)
0.
00
2
Ev
er
sm
ok
er
,
%
(n
)
78
.8
(8
69
)
70
.5
(6
95
)
71
.0
(5
12
)
69
.8
(3
45
)
71
.5
(5
41
)
<
0.
00
1
Ph
ys
ic
al
ac
tiv
ity
(e
xe
rc
is
e
un
its
)b
36
3.
7
(2
25
.0
-5
36
.0
)
34
7.
5
(2
17
.9
-5
01
.6
)
34
1.
9
(2
15
.4
-5
21
.0
)
34
9.
5
(2
15
.0
-5
28
.6
)
27
9.
2
(1
72
.3
-4
26
.1
)
<
0.
00
1
Al
co
ho
l
(m
l/d
ay
)b
7.
2
(1
.2
-1
7.
8)
7.
5
(1
.6
-1
7.
9)
6.
4
(1
.4
-1
8.
0)
6.
2
(1
.0
-1
8.
0)
3.
3
(0
.3
-1
0.
8)
<
0.
00
1
Cl
in
ic
al
an
d
ph
ys
ic
al
ch
ar
ac
te
ris
tic
s
Ba
se
lin
e
BM
I
(k
g/
m
2 )
20
.6
(1
.8
)
22
.5
(2
.1
)
23
.6
(2
.1
)
24
.8
(2
.2
)
26
.2
(2
.4
)
<
0.
00
1
Ba
se
lin
e
w
ai
st
ci
rc
um
fe
re
nc
e
(c
m
)
69
.8
(6
.1
)
73
.8
(7
.0
)
76
.7
(7
.7
)
79
.5
(8
.0
)
80
.6
(7
.8
)
<
0.
00
1
Sy
st
ol
ic
bl
oo
d
pr
es
su
re
(m
m
H
g)
b
10
7.
5
(9
.5
)
11
0.
3
(9
.5
)
11
1.
6
(9
.0
)
11
3.
6
(9
.7
)
11
4.
0
(9
.5
)
<
0.
00
1
D
ia
st
ol
ic
bl
oo
d
pr
es
su
re
(m
m
H
g)
b
67
.7
(7
.5
)
69
.6
(7
.5
)
70
.7
(7
.2
)
72
.2
(7
.5
)
73
.3
(7
.4
)
<
0.
00
1
Ev
er
an
tih
yp
er
te
ns
iv
e
m
ed
ic
at
io
n,
%
(n
)
7.
9
(8
7)
17
.4
(1
72
)
20
.3
(1
46
)
24
.9
(1
23
)
36
.6
(2
77
)
<
0.
00
1
Ev
er
lip
id
-l
ow
er
in
g
m
ed
ic
at
io
n,
%
(n
)
4.
1
(4
5)
11
.3
(1
11
)
13
.3
(9
6)
15
.8
(7
8)
17
.6
(1
33
)
<
0.
00
1
Ev
er
di
ab
et
es
,
%
(n
)c
2.
4
(2
6)
6.
0
(5
9)
8.
3
(6
0)
14
.2
(7
0)
20
.9
(1
58
)
<
0.
00
1
Fa
st
in
g
bl
oo
d
co
nc
en
tr
at
io
nb
Gl
uc
os
e
(m
g/
dl
)
86
.8
(1
4.
6)
89
.8
(1
4.
8)
91
.3
(1
3.
4)
93
.1
(1
0.
7)
94
.4
(1
4.
2)
<
0.
00
1
In
su
lin
(m
U/
m
l)
8.
8
(4
.3
)
10
.5
(4
.7
)
12
.0
(5
.2
)
14
.0
(5
.5
)
17
.0
(7
.8
)
<
0.
00
1
To
ta
l
ch
ol
es
te
ro
l
(m
g/
dl
)
17
3.
1
(2
7.
3)
18
1.
5
(2
9.
4)
18
4.
0
(2
9.
6)
18
5.
2
(3
0.
3)
18
3.
2
(2
9.
0)
<
0.
00
1
H
D
L-
ch
ol
es
te
ro
l
(m
g/
dl
)
58
.3
(1
3.
7)
54
.8
(1
2.
6)
51
.6
(1
1.
9)
49
.3
(1
1.
4)
49
.4
(1
1.
2)
<
0.
00
1
Tr
ig
ly
ce
rid
es
(m
g/
dl
)
64
.0
(5
1.
0-
82
.8
)
73
.0
(5
6.
3-
98
.4
)
81
.0
(5
9.
5-
10
6.
6)
91
.0
(6
7.
1-
12
1.
0)
87
.0
(6
3.
9-
11
8.
8)
<
0.
00
1
a
P
re
se
n
te
d
a
s
th
e
m
e
a
n
(S
D
),
m
e
d
ia
n
(IQ
R
),
o
r
%
(n
)
a
s
a
p
p
ro
p
ria
te
.
b
B
a
se
d
u
p
o
n
th
e
a
ve
ra
g
e
o
f
a
ll
a
va
ila
b
le
va
lu
e
s.
c
D
ia
b
e
te
s
d
e
fin
e
d
a
s
a
se
lf-
re
p
o
rt
o
f
o
ra
l
h
yp
o
g
ly
c
e
m
ic
m
e
d
ic
a
tio
n
s
o
r
in
su
lin
a
t
e
xa
m
in
a
tio
n
ye
a
rs
2
,
5
,
7
,
1
0
,
1
5
,
2
0
,
a
n
d
2
5
;
fa
st
in
g
g
lu
c
o
se
le
ve
ls
7
.0
m
m
o
l/
l
(
1
2
6
m
g
/d
l)
a
t
e
xa
m
in
a
tio
n
ye
a
rs
7
,
1
0
,
1
5
,
2
0
,
o
r
2
5
;
a
2
-h
p
o
st
lo
a
d
g
lu
c
o
se
1
1
.1
m
m
o
l/
l
(
2
0
0
m
g
/d
l)
a
t
e
xa
m
in
a
tio
n
ye
a
rs
1
0
,
2
0
,
a
n
d
2
5
;
o
r
a
g
ly
c
a
te
d
h
e
m
o
g
lo
b
in
A
1
c
6
.5
%
a
t
ye
a
rs
2
0
a
n
d
2
5
.
Original Article Obesity
EPIDEMIOLOGY/GENETICS
www.obesityjournal.org Obesity | VOLUME 23 | NUMBER 4 | APRIL 2015 881
for CVD, CHD, and HF according to excess BMI- and waist
circumference-years. Excess BMI- and waist circumference-years
were included as time-dependent variables in one of two exposure
forms: first as a continuous variable (per 50 excess BMI- and waist
circumference-years) assuming a linear dose-response association,
and second as a five-level categorical variable (i.e., 0, 1-49, 50-99,
100-149, and 150 excess BMI- and 0, 1-99, 100-199, 200-299, and
300 waist circumference-years). Fifty excess BMI-years (or waist
circumference-years) is approximately equal to a BMI of 30 kg/m2
(or a waist circumference of 100 cm for men and 86 cm for women)
for 8 years, for example. Analyses were adjusted for age, sex, race,
CARDIA field center, and the following time-dependent covariates:
education, smoking, alcohol use, physical activity, and energy
intake. A second model adjusted additionally for the following time-
dependent variables: systolic blood pressure, fasting insulin, total
cholesterol, HDL-cholesterol, triglycerides, diabetes, and antihyper-
tensive and lipid-lowering medication, separately. Average values
reflect the mean of all available measures up until the date of the
event or censoring. The additional adjustment variables in the sec-
ond model could be in the causal pathway between excess BMI-
and waist circumference-years and CVD, CHD, and HF; we
regarded these models as possibly explanatory. Given the strong cor-
relation between BMI and waist circumference (r> 0.80), we did
not mutually adjust for overall and abdominal adiposity.
To compare the predictive value of excess BMI- and waist
circumference-years with BMI and waist circumference only, respec-
tively, we divided each of these time-dependent variables into equal
categories defined by a not overweight/obese category and deciles
for the remaining categories. We used the Akaike information crite-
rion (AIC), computed as -2*(log-likelihood)1 2*(number of esti-
mated parameters), as a measure of goodness of fit, to compare the
models (13). A lower AIC indicates better fit.
We performed two sensitivity analyses. In the first, we used alter-
nate thresholds to define an excess degree of overall (BMI 22 and
30 kg/m2) and abdominal adiposity (waist circumference >90 and
>102 cm for men and >76 and >88 cm for women). In the second,
we accounted for missing BMI and waist circumference values from
the follow-up examinations (18% of all measurements for each) on
the sample of 4,061 participants using the sequential regression
imputation approach that is implemented in the software package
IVEware (14). Five datasets were generated using all available BMI
and waist circumference data. Each dataset was analyzed separately
and results from the five analyses were combined using the rules of
Little and Rubin (15).
Tests of statistical significance were two-tailed, with an alpha level
of 0.05. SAS version 9.3 (SAS Institute, Cary, NC) was used to per-
form all analyses.
Results
Of the 4,061 eligible participants, 48.4% were black and 49.7%
were women. The mean (standard deviation) and median (interquar-
tile range) excess BMI-years were 76.6 (90.6) and 47.0 (0-121.0),
TABLE 2 Hazard ratios (HR) and 95% confidence intervals (CI) for cardiovascular disease, coronary heart disease, and heart
failure according to excess body mass index (BMI)-years, The CARDIA study (n54,061)
Excess BMI-years
0
(n5 1,103)
1-49
(n5986)
50-99
(n5 721)
100-149
(n5 494)
150
(n5 757) P-trend
Per 50 excess
BMI-yearsa
Cardiovascular disease
No. of events 22 28 22 16 37
Event rateb 0.86 1.12 1.27 1.33 2.02
Model 1 HR (95% CI)c 1.00 (ref) 1.58 (0.94-2.67) 1.45 (0.79-2.65) 1.79 (0.92-3.51) 2.76 (1.49-5.09) <0.001 1.20 (1.08-1.34)
Model 2 HR (95% CI)d 1.00 (ref) 1.14 (0.62-2.09) 0.89 (0.43-1.82) 0.74 (0.32-1.70) 0.90 (0.43-2.44) 0.82 0.98 (0.84-1.14)
Coronary heart disease
No. of events 6 17 12 10 17
Event rateb 0.23 0.71 0.69 0.83 0.92
Model 1 HR (95% CI)c 1.00 (ref) 3.55 (1.45-8.72) 2.86 (1.05-7.78) 4.24 (1.48-12.11) 5.40 (1.91-15.26) 0.006 1.25 (1.07-1.46)
Model 2 HR (95% CI)d 1.00 (ref) 2.62 (0.87-7.93) 2.05 (0.60-7.01) 2.46 (0.67-8.99) 2.11 (0.53-8.48) 0.59 1.06 (0.86-1.32)
Heart failure
No. of events 3 6 2 5 17
Event rateb 0.12 0.25 0.11 0.41 0.92
Model 1 HR (95% CI)c 1.00 (ref) 2.05 (0.53-7.96) 2.58 (0.61-11.01) 6.16 (1.53-24.81) 8.47 (2.17-33.08) <0.001 1.45 (1.23-1.72)
Model 2 HR (95% CI)d 1.00 (ref) 3.25 (0.39-27.37) 4.11 (0.44-28.44) 4.23 (0.42-42.36) 5.99 (0.60-59.34) 0.02 1.32 (1.05-1.66)
a50 excess BMI-years is approximately equal to a BMI of 30 kg/m2 for 8 years, for example.
bPer 1,000 person-years.
cAdjusted for age, race (black/white), sex, study center, and time-varying education (maximum years), smoking (current or former/never), alcohol use (average ml/day),
physical activity (average exercise units), and energy intake (average kcal).
dAdjusted additionally for time-varying systolic blood pressure (average mmHg), insulin (average mU/ml), total cholesterol (average mg/dl), HDL-cholesterol (average mg/dl),
triglycerides (average mg/dl), diabetes (yes/no), and medication use for high blood pressure or high cholesterol (separately) (yes/no).
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respectively, and 97.3 (153.3) and 9.0 (0-122.3) for excess waist
circumference-years. Approximately 27.2% and 40.9% of partici-
pants never achieved a BMI 25.0 kg/m2 or waist circumference
>94 cm (men) or >80 cm (women), respectively, during follow-up,
and therefore had 0 excess BMI- and waist circumference-years.
Table 1 shows the characteristics of participants according to cate-
gories of excess BMI-years accumulated. Those with greater expo-
sure to excess BMI-years were more likely to be black, achieve less
education, were less likely to smoke, report less physical activity,
and consume less alcohol. In addition, participants with greater
excess BMI-years had higher average blood pressures; higher glu-
cose, insulin, and lipid levels; were more likely to use antihyperten-
sive and lipid-lowering medication; and were more likely to develop
diabetes during follow-up. Baseline age and sex were unrelated to
excess BMI-years accumulation. Similar results were observed when
excess BMI-years was substituted with excess waist circumference-
years, except women were more likely to have higher excess waist
circumference-years (data not shown).
During a median 24.8 years of follow-up (35,478,786 person-years),
there were 125 total CVD, 62 CHD, and 33 HF events. Table 2
shows adjusted HRs and 95% CIs for total CVD, CHD, and HF
according to excess BMI-years. Rates per 1,000 person-years were
higher with greater exposure to excess BMI-years. Adjusted HRs for
CVD, CHD, and HF for each additional 50 excess BMI-years were
1.20 (95% CI: 1.08-1.34), 1.25 (95% CI: 1.07-1.46), and 1.45 (95%
CI: 1.23-1.72), respectively. Associations were attenuated, but
persisted for HF following further adjustment for potential interme-
diate factors (Table 2, model 2).
Table 3 shows adjusted HRs and 95% CIs for total CVD, CHD, and
HF according to excess waist circumference-years. Similar to excess
BMI-years, rates per 1,000 person-years were higher with greater
excess waist circumference-years. Adjusted HRs for CVD, CHD,
and HF for each additional 50 excess waist circumference-years
were 1.10 (95% CI: 1.04-1.18), 1.13 (95% CI: 1.03-1.24), and 1.22
(95% CI: 1.11-1.34), respectively. Associations were attenuated and
no longer statistically significant following further adjustment for
potential intermediates (Table 3, model 2).
Table 4 shows AIC values comparing time-varying BMI and waist
circumference with excess BMI- and waist circumference-years in
the prediction of total CVD, CHD, and HF. Compared with models
which included time-varying BMI only in the prediction of total
CVD events and heart failure, models containing time-varying
excess BMI-years exhibited lower AIC values. Similar results were
observed in models which included waist circumference only vs.
excess waist circumference-years, with the exception of CHD.
In the first sensitivity analysis, measures of association and AIC val-
ues were similar when we used alternative thresholds to define an
excess degree of overall (BMI 22 and 30 kg/m2) and abdominal
adiposity (waist circumference >90 and >102 cm for men and >76
and >88 cm for women) (data not shown). In the second, when we
imputed missing measurements of BMI and waist circumference
TABLE 3 Hazard ratios (HR) and 95% confidence intervals (CI) for cardiovascular disease, coronary heart disease, and heart
failure according to excess waist circumference-years, The CARDIA study (n5 4,061)
Excess waist circumference-years
0
(n51,711)
1-99
(n5 1,210)
100-199
(n5471)
200-299
(n5273)
300
(n5 396) P-trend
Per 50
excess waist
circumference-
yearsa
Cardiovascular disease
No. of events 36 40 18 15 16
Event rateb 0.90 1.35 1.57 2.26 1.66
Model 1 HR (95% CI)c 1.00 (ref) 1.78 (1.16-2.74) 2.13 (1.19-3.80) 2.16 (1.02-4.58) 2.58 (1.26-5.32) 0.003 1.10 (1.04-1.18)
Model 2 HR (95% CI)d 1.00 (ref) 1.30 (0.77-2.20) 1.09 (0.53-2.23) 1.01 (0.40-2.57) 0.66 (0.24-1.80) 0.51 0.97 (0.88-1.07)
Coronary heart disease
No. of events 16 24 9 8 5
Event rateb 0.40 0.81 0.78 1.19 0.52
Model 1 HR (95% CI)c 1.00 (ref) 2.34 (1.26-4.35) 2.10 (0.85-5.17) 4.39 (1.74-11.03) 2.83 (0.89-8.99) 0.01 1.13 (1.03-1.24)
Model 2 HR (95% CI)d 1.00 (ref) 1.88 (0.88-4.06) 1.41 (0.47-4.20) 2.11 (0.62-7.21) 0.72 (0.13-4.00) 0.80 0.98 (0.85-1.13)
Heart failure
No. of events 8 5 4 6 10
Event rateb 0.20 0.17 0.35 0.90 1.04
Model 1 HR (95% CI)c 1.00 (ref) 1.29 (0.46-3.62) 5.07 (1.83-14.05) 3.35 (0.83-13.57) 6.47 (1.94-21.50) <0.001 1.22 (1.11-1.34)
Model 2 HR (95% CI)d 1.00 (ref) 0.93 (0.26-3.32) 2.30 (0.58-9.04) 1.27 (0.19-8.35) 2.07 (0.37-11.50) 0.28 0.99 (0.98-1.01)
a50 excess waist circumference-years is approximately equal to a waist circumference of 100 cm for men and 86 cm for women for 8 years, for example.
bPer 1,000 person-years.
cAdjusted for age, race (black/white), sex, study center, and time-varying education (maximum years), smoking (current or former/never), alcohol use (average ml/day),
physical activity (average exercise units), and energy intake (average kcal).
dAdjusted additionally for time-varying systolic blood pressure (average mmHg), insulin (average mU/ml), total cholesterol (average mg/dl), HDL-cholesterol (average mg/dl),
triglycerides (average mg/dl), diabetes (yes/no), and medication use for high blood pressure or high cholesterol (separately) (yes/no).
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from the follow-up examinations on the sample of 4,061 partici-
pants, HRs adjusted for model 1 covariates for each additional 50
excess BMI-years for CVD, CHD, and HF were 1.15 (95% CI:
1.03-1.29), 1.18 (95% CI: 1.00-1.79), and 1.40 (95% CI: 1.19-1.66),
respectively, and 1.08 (95% CI: 1.01-1.16), 1.09 (95% CI: 0.98-
1.21), and 1.22 (95% CI: 1.10-1.34) for each additional 50 excess
waist circumference-years.
Neither excess BMI-years nor excess waist circumference-years
were associated with incident stroke (32 events) [HRs adjusted for
model 1 covariates for each additional 50 excess BMI- and waist
circumference-years were 0.90 (95% CI: 0.70-1.17) and 0.95 (95%
CI: 0.81-1.12), respectively].
Discussion
In this community-based longitudinal cohort study of young adults
recruited and followed largely during the obesity epidemic over the
last three decades in the United States, we found measures of the
cumulative burden of excess overall and abdominal adiposity were
strongly associated in a graded and similar fashion with incident
CVD. As expected, this association was largely explained by several
traditional metabolic CVD risk factors that may lie on the causal
pathway between excess adiposity and the development of a CVD
event. In addition, excess BMI- and waist circumference-years pro-
vided more discriminative power than those which included BMI or
waist circumference alone. These findings suggest that the greater
cumulative exposure to a higher degree and longer duration of
excess adiposity will have important implications on the future bur-
den of CVD in the United States.
We are unaware of longitudinal studies that have simultaneously
measured and combined information regarding both the degree and
duration of excess adiposity in the prediction of CVD. However, we
note that our findings are consistent with a limited number of stud-
ies that have suggested the construct of excess BMI-years is associ-
ated with other adverse health-related outcomes, including diabetes,
and may provide a better indicator of the health risks of increasing
body weight than simply the degree of adiposity. In the National
Longitudinal Survey of Youth 1979, excess BMI-years based on
repeat reports of height and weight from 1981 through 2006 was
strongly associated with the development of diabetes (16). In addi-
tion, models which contained excess BMI-years had areas under the
receiver operator characteristic curve that were larger than those that
included only baseline BMI (16). However, no additional measures
of adiposity were available. In the Framingham Heart Study, each
additional 10 excess BMI-years calculated from repeat measure-
ments of BMI over 48 years beginning in 1948 was associated with
a 7% higher incidence of diabetes (17). AIC values were lowest in
models containing excess BMI-years than those which contained
BMI only (17). However, rates of obesity were much lower in the
United States over six decades ago and no other measures of adipos-
ity were available. The primary strengths of the current study
include the replicate assessments of both BMI and waist circumfer-
ence collected every 2-5 years via a standardized protocol during a
long follow-up period over the course of the obesity epidemic in the
United States.
In the current study, we found that models predicting risk of CVD
containing time-varying excess BMI- and waist circumference-years
had lower AIC values than similar models that evaluated time-
varying BMI and waist circumference only, results that were largely
due to enhanced prediction of HF. Although it was not possible to
perform a statistical comparison between models since they were
non-nested, the AIC provides an objective way of determining
which model among a set of models is most parsimonious. The
exact value of the AIC for a given set of data has no meaning; how-
ever, when the AIC of a series of models is compared, the model
with the lowest AIC is often referred to as the best model among all
models specified. As a rule of thumb, models with a difference in
AIC values of 2, 3-10, and >10 have little, considerable, and sub-
stantial evidence, respectively, for a difference between models (18).
Thus, differences in the AIC values for CVD, which ranged from 4
to 5, suggest considerable support for both excess BMI- and waist
circumference-years as improved predictors of CVD (18). To esti-
mate the cumulative effects of a greater degree and longer duration
of exposure to excess overall and abdominal adiposity as a result of
the obesity epidemic, future studies should attempt to measure both
the degree and duration of excess adiposity.
Our findings showed that greater exposure to excess BMI- and waist
circumference-years was associated with higher levels of blood pres-
sure, insulin, triglycerides, and total cholesterol, greater use of anti-
hypertensive and lipid-lowering medications, higher rates of diabe-
tes, and lower levels of HDL-cholesterol during follow-up. As
expected, these potential intermediate metabolic CVD risk factors
largely explained the association between excess BMI- and waist
circumference-years and the development of CVD. However, the
association of excess BMI-years with HF remained following adjust-
ment for these factors. Additional mechanisms that may explain, at
TABLE 4 Akaike information criterion values comparing time-varying body mass index (BMI) and waist circumference with
time-varying excess BMI- and waist circumference-years in the prediction of total cardiovascular disease, coronary heart
disease, and heart failure, The CARDIA study (n54,061)
Time-varying exposures
BMI Excess BMI-years
Waist
circumference
Excess waist
circumference-years
Cardiovascular disease 1,946 1,941 1,943 1,939
Coronary heart disease 939 938 944 945
Heart failure 521 516 519 512
Obesity Excess Adiposity and Cardiovascular Disease Reis et al.
884 Obesity | VOLUME 23 | NUMBER 4 | APRIL 2015 www.obesityjournal.org
least in part, the association of excess overall adiposity with HF
include sustained expression and secretion of proinflammatory adi-
pocytokines, myocyte hypertrophy, myocardial fibrosis, sleep disor-
dered breathing, and alterations in cardiac structure and function
(19).
Strengths of the current study include a community-based sampling
method; cohort recruitment and follow-up largely during the obesity
epidemic of the last three decades; a biracial cohort; extensive data
on potential confounders; a large sample size well balanced with
respect to age, sex, race, and education that increased precision and
permitted simultaneous adjustment by multiple variables; repeat
assessments of BMI and waist circumference (and potential con-
founding and intermediate factors) starting at a young age, minimiz-
ing the potential for reverse causation; a high retention rate; verifi-
cation and adjudication of CVD events; and the standardized data
collection protocols and rigorous quality control of the CARDIA
study. Nevertheless, at least four limitations deserve mention. First,
our estimation of excess overall and abdominal adiposity during
follow-up was based on the measurement of BMI and waist circum-
ference, respectively, every 2-5 years. It is likely that a more fre-
quent number of assessments would have led to a more accurate
estimation; however, to the extent that there was random misclassifi-
cation due to this assessment schedule, we may have underestimated
the true association in our cohort. Second, because our study col-
lected data over a 25-year follow-up period, some participants were
missing at least one eligible measurement of BMI and waist circum-
ference. However, we noted similar results (except for the associa-
tion of excess waist circumference-years and CHD) between our
multiple imputed datasets and our primary dataset that accounted for
missing BMI and waist circumference using the average value from
adjacent follow-up examinations. Third, although we defined an
excess degree of overall and abdominal adiposity using recom-
mended cut-points, it is unlikely that the adverse metabolic effects
of excess adiposity begin to occur only at these levels. However, we
noted no appreciable differences in models that set alternative defi-
nitions for these thresholds. Fourth, the relatively small number of
outcomes in our study limited the precision of our estimates and our
ability to perform stratified analyses.
In conclusion, our findings indicate that combined measures of the
degree and duration of excess overall and abdominal adiposity
strongly predict risk of new-onset CVD in a dose-response fashion.
In addition, in nearly all instances, excess BMI- and waist
circumference-years better predicted risk of CVD than BMI or waist
circumference alone. This information is critical to understanding
the consequences of a greater cumulative exposure to excess
adiposity over the life course as a result of the obesity epidemic.
These findings suggest that future public health interventions
focused on CVD prevention should focus on younger populations to
prevent or at least delay the development of excess adiposity.O
VC 2015 The Obesity Society
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